Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

QIAGEN and Myriad Genetics Team Up to Create Global HRD Test for Research and Companion Diagnostics

Friday, May 31, 2024

QIAGEN and Myriad Genetics have announced a partnership to create a globally distributable kitbased test for analyzing Homologous Recombination Deficiency status This nextgeneration sequencing test aims

Dupilumab (Dupixent) Recommended for COPD Treatment Approval by EU CHMP

Friday, May 31, 2024

Regeneron Pharmaceuticals Inc and Sanofi have jointly announced that the European Medicines Agencys Committee for Medicinal Products for Human Use has issued a favorable opinion recommending the approval of Dupixent in the European Union

Larimar Therapeutics Receives FDA Nod to Join START Pilot Program for Nomlabofusp in Friedreich’s Ataxia

Friday, May 31, 2024

Larimar Therapeutics Inc a company in the biotechnology sector focusing on rare diseases has announced that the FDA has selected nomlabofusp to participate in the Support for Clinical Trials Advancing Rare

BioNTech and CEPI Partner to Enhance Africa's mRNA Vaccine Ecosystem

Thursday, May 30, 2024

BioNTech SE and the Coalition for Epidemic Preparedness Innovations are expanding their strategic partnership to establish a robust and sustainable vaccine manufacturing ecosystem in Africa CEPI will provide up to million to support BioNTech in sett...

Fusion Pharmaceuticals Acquisition by AstraZeneca Gets Shareholder Approval

Thursday, May 30, 2024

Fusion Pharmaceuticals Inc a company in the field of oncology focusing on the development of advanced radio conjugates as targeted therapies made an announcement today regarding the results of a special virtual meeting of its shareholders At this me...

Roche's Inavolisib Receives FDA Priority Review for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer with PIK3CA Mutation

Thursday, May 30, 2024

Roche announced today that the US Food and Drug Administration has accepted its New Drug Application and granted Priority Review to inavolisib an investigational oral therapy in combination with palbociclib

Aprea Therapeutics' Safety Review Committee Approves 800 mg Dosing of ATRN-119 in ABOYA-119 Trial

Wednesday, May 29, 2024

Aprea Therapeutics Inc a clinicalstage biopharmaceutical company focused on precision oncology through synthetic lethality announced that the Safety Review Committee

Cytek® Biosciences Gains Approval for 1-Laser and 2-Laser 6-Color TBNK Reagents for Clinical Use in China

Wednesday, May 29, 2024

Cytek Biosciences Inc has announced that its laser and laser color TBNK reagent cocktails have received approval from the China National Medical Products Administration for clinical diagnostic use on the Cytek

FDA Approves Initial Interchangeable Biosimilar for Two Rare Conditions

Wednesday, May 29, 2024

Today the US Food and Drug Administration authorized Bkemv as the inaugural interchangeable biosimilar to Soliris for treating specific rare diseases Bkemv has been endorsed for treating the following indications which are presently also approved for...

FDA Prioritizes Review of Sarclisa for Newly Diagnosed Multiple Myeloma Patients Excluded from Transplant Eligibility

Tuesday, May 28, 2024

The US Food and Drug Administration has given priority review status to the Supplemental Biologics License Application for Sarclisa in combination with bortezomib lenalidomide and dexamethasone